SCHEMBL30737217

SCHEMBL30737217

COC(=O)[C@H](CCC(C)(C)C)NC(=O)COc1cccc(Oc2ccc(OC3CCNCC3)cn2)c1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SORT1 Q99523 3/20 0.43
GRN P28799 2/20 0.43
ACACB O00763 7/20 0.41
ACACA Q13085 5/20 0.41
MEN1 O00255 1/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
KMT2A Q03164 1/20 0.38
MAPT P10636 1/20 0.37
CSF1R P07333 1/20 0.36
FLT3 P36888 1/20 0.36
ROCK2 O75116 1/20 0.36
ROCK1 Q13464 1/20 0.36
CTSD P07339 1/20 0.35
RECQL P46063 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30737006 0.86 SORT1 (0.59) SORT1GRNACACBACACALMNA
SCHEMBL30737430 0.85 YAP1 (0.45) SORT1GRNACACBACACAMEN1
SCHEMBL30737266 0.82 SORT1 (0.37) SORT1GRNACACBACACALMNA
SCHEMBL30737185 0.81 SORT1 (0.38) SORT1GRNACACBACACALMNA
SCHEMBL30737412 0.80 SORT1 (0.61) SORT1GRN
SCHEMBL31646849 0.77 SORT1 (0.51) SORT1GRNMEN1ALDH1A1LMNA
SCHEMBL30737310 0.77 SORT1 (0.53) SORT1GRNKMT2AMAPTROCK2
SCHEMBL31646544 0.77 SORT1 (0.51) SORT1GRNACACBACACAMEN1
SCHEMBL30737298 0.76 SORT1 (0.67) SORT1GRNACACBACACAMEN1
SCHEMBL30737228 0.75 SORT1 (0.59) SORT1GRNMEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250345446-A1 BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES DRAUPNIR BIO APS (DK) 2025-11-13 US disclosed
EP-4543858-A1 BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES Draupnir Bio ApS (DK) 2025-04-30 EP disclosed
WO-2023247754-A1 BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES DRAUPNIR BIO APS (DK) 2023-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250345446-A1 BIFUNCTIONAL MOLECULES THAT SELECTIVELY INDUCE DEGRADATION OF EXTRACELLULAR TARGETS IN LYSOSOMES SORT1, SCARB1, LAMP1 SORT1 1/4885GRN 842/4885ACACB 3385/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.